Skip to content

Acupuncture for Precocious Puberty in Girls: A Randomized Controlled Trial

Acupuncture for Precocious Puberty in Girls: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000545
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precocious puberty in girls

Interventions

Acupuncture group:Acupuncture
Sham acupuncture group:Sham acupuncture

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
5 Years to 10 Years

Inclusion criteria

Inclusion criteria: (1) Female child shows breast development as a secondary sexual characteristic before the age of 8; (2) Breast Tanner staging does not exceed stage III; (3) Serum gonadotropins and sex hormone levels are at prepubertal levels (basal serum LH 4 mm in one ovary, uterine length < 3.4 cm, or uterine volume < 2.5 ml; (5) Bone age is 1 year or more ahead of chronological age; (6) Conduct ß-HCG, alpha-fetoprotein (AFP), and cranial MRI examinations to exclude intracranial tumors and other organic diseases; (7) Patient and parents agree and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Central precocious puberty with rapid progression; (2) Female pseudo-precocious puberty; (3) Precocious puberty caused by other organic diseases, such as gonadal tumors or adrenal tumors; (4) Suspected chromosomal abnormalities or genetic diseases accompanied by unusual appearance, skin abnormalities, or growth and development disorders; (5) Not meeting the inclusion criteria or unable to adhere to the treatment course; (6) Treatment with other medications or interventions; (7) Participants currently involved in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Breast Tanner Staging;

Secondary

MeasureTime frame
Anthropometric Indices;Serum sex hormone levels;Pelvic ultrasound parameters;TCM syndrome score;Safety Evaluation;

Countries

China

Contacts

Public ContactLiu Lili

Beijing Jishuitan Hospital, Capital Medical University

liulili2005@126.com13426324221

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026